Verto vs Aspyre by Mosaique

Platform comparison

Aspyre by Mosaique is the most established NHS-specific PPM platform in the UK market, with over 50 NHS organisations and a marquee NHS England reference. If you are evaluating portfolio management software for an NHS or health and care context, this comparison is worth reading carefully, both platforms have genuine strengths, and the differences matter depending on exactly what you need to deliver.

In short

Aspyre is the deepest NHS-specific PPM platform available and is the right choice for many NHS organisations operating within a single-vertical footprint. Where it begins to show limits is in ICB-level portfolio management across non-NHS bodies, modern integration requirements, AI capability and the vendor scale expected for long-term mission-critical contracts.

Aspyre · Mosaique

Aspyre by Mosaique

A UK PPM platform built specifically for NHS organisations, founded in 2005 by MSP and PRINCE2 practitioners. 22 modules and 200+ NHS best-practice reports. Dominant in NHS PPM with NHS England as its most prominent reference.

Best for: NHS-specific portfolio and programme management
Founded: 2005 — Solihull, UK (Mosaique Ltd)
Team size: ~9 staff, family-run (micro-entity)
G-Cloud: G-Cloud 14 listed
Hosting: UK — Tier 4 / AWS UK region
NHS references: 50+ NHS organisations
Non-NHS refs: None verified
AI roadmap: Not published

Verto Cloud

Verto

A dedicated P3M platform built for UK public sector over 17 years. Used across NHS, central government, local authorities, MOD and housing. Designed for PMO Directors, SROs and portfolio leads managing complex, cross-sector delivery landscapes.

Best for: Cross-sector UK public sector P3M governance
Founded: 2009 — UK
Team size: UK-scale organisation
G-Cloud: G-Cloud approved
Hosting: UK-hosted
NHS references: Multiple NHS clients
Non-NHS refs: 100+ across all public sector verticals
AI roadmap: Built into platform

£2.5bn NHS England portfolio managed via Aspyre

NHS England is Aspyre's headline reference, and it is a significant one. Managing a £2.5bn portfolio of National Programmes is not a trivial deployment. For NHS organisations evaluating PPM platforms, this reference carries genuine weight — it indicates that Aspyre has proven itself at scale within the NHS system.

It is worth being direct about this: if you are an NHS Trust or ICB evaluating Aspyre, this reference matters and should not be dismissed. Aspyre has earned its position in the NHS market through genuine domain expertise, and founder Claire Cassidy's background as one of the UK's earliest MSP Advanced Practitioners is reflected in how the platform is designed.

The more useful question is what the NHS England reference tells you about Aspyre's fit for your specific situation — particularly if your portfolio extends beyond NHS organisational boundaries, or if you need your platform to be part of a modern data and integration estate.

Aspyre is well-suited when…

Your organisation is an NHS Trust or other single NHS body with no cross-sector portfolio complexity
Your P3M framework is firmly based on MSP and PRINCE2 and you want that methodology embedded in the platform
Your portfolio partners are all NHS organisations
NHS-specific best-practice reports and benchmarking are a priority
You are comfortable with a smaller, specialist vendor and the procurement risk that carries
Integration with Power BI, Teams or ServiceNow is not a current requirement

Verto is the stronger choice when…

You are an ICB managing programmes across NHS and non-NHS partners
Your portfolio includes central government, local authority, housing or VCSE delivery partners
IPA, MoP or GovS 002 alignment is required alongside MSP
You need integration with Power BI, Teams or your existing data estate
AI capability is part of your near-term platform requirements
Long-term vendor scale, balance sheet and governance are factors in your procurement risk assessment
You need cross-sector deployment evidence from similar organisations

		Aspyre by Mosaique
NHS-specific P3M depth	Strong — proven NHS deployments	Market-leading — 22 modules, 200+ NHS reports
Cross-sector P3M (non-NHS)	Full cross-sector — central gov, councils, MOD, housing	NHS-only architecture
ICB cross-partner roll-up	NHS and non-NHS partners	NHS bodies only
MSP / PRINCE2 / P3O alignment	Fully supported	Embedded by founder practitioners
IPA / MoP / GovS 002 alignment	Built in by design	Not natively aligned
Benefits realisation	Built in — Green Book aligned	Built in
G-Cloud listing	G-Cloud approved	G-Cloud 14 — £15–£30/seat/month
UK data hosting	UK-hosted	Tier 4 / AWS UK
Power BI integration	Available	Not available
Microsoft Teams integration	Available	Not available
AI features (shipped)	Built into platform	No published roadmap
Product development cadence	Regular releases	Incremental — v10.3 (2025)
Vendor scale	UK-scale, appropriate for long-term contracts	~9 staff, micro-entity, family-run
External governance	Commercial governance structure	Family directors only, no external oversight
UK public sector refs (non-NHS)	Central gov, councils, MOD, housing	None verified

What Aspyre does genuinely well

Deepest NHS-specific P3M platform in the market — 22 modules built for NHS workflows
200+ NHS best-practice reports — significant for organisations that want pre-built NHS governance templates
Founder methodology expertise is genuine — MSP and PRINCE2 embedded at platform level
NHS England £2.5bn reference is a credible, large-scale NHS deployment
G-Cloud listed and UK-hosted — procurement and data sovereignty both sound
50+ NHS organisations — a deep NHS reference base that carries weight in NHS procurement
Long-standing UK vendor — founded 2005, 20 years of NHS domain focus

Where Aspyre reaches its limits

NHS-only architecture — non-NHS organisations cannot be meaningfully included in the portfolio
ICB cross-partner roll-up across local authorities, housing and VCSE requires workarounds
No Power BI, Teams or ServiceNow integration — sits outside the modern M365 stack
No published AI roadmap — a gap that will widen as peers invest in AI-assist features
Incremental product development — v10.3 in 2025 suggests patch cadence rather than platform evolution
Nine staff, micro-entity balance sheet — vendor concentration risk for long-term contracts
Family-only directors, no external governance or investor oversight
Messaging only beginning to broaden beyond NHS — non-NHS deployments are unproven

Questions to put to Aspyre

Can you show us three non-NHS public sector customers with deployment evidence — council, central government, MOD or housing? Establishes whether the broadening 'regulated sectors' messaging reflects real deployments or future intent.
For an ICB managing programmes across NHS Trusts, councils and housing partners — how does Aspyre handle non-NHS organisations in the same portfolio view? Tests the ICB cross-partner architecture directly and surfaces the NHS-only data model constraint.
What is your published AI and integration roadmap for 2026 and 2027? Forces a conversation about the absence of an AI roadmap and the gap in Power BI and Teams integration.
Which UK government frameworks beyond NHS does your data model align to — GovS 002, IPA Routemap, HMT Green Book? Exposes NHS-specific architecture and tests readiness for IPA or cross-departmental assurance.
For a multi-year mission-critical contract, what is your vendor scale, balance sheet and external governance structure? Surfaces the micro-entity and family-run governance model in a procurement context where vendor viability matters.
What is your business continuity plan if key personnel were unavailable for an extended period? A nine-person family business with no external governance is inherently concentrated. This question should be asked and answered contractually.

17 years serving UK public sector

100+ government clients

G-Cloud approved & procurement-ready

MoP MSP & IPA aligned by design

Is Aspyre by Mosaique available on G-Cloud?

Yes. Aspyre by Mosaique is listed on G-Cloud 14 at £15 to £30 per seat per month. The platform is UK-hosted via Tier 4 data centres and AWS UK region, and is directly procurable through G-Cloud without additional justification. This is a genuine strength in NHS procurement. Verto is also G-Cloud approved and procurable on the same basis.

Can Aspyre support portfolio management outside the NHS?

Aspyre was built for the NHS and its architecture, best-practice reports and reference base are NHS-specific. As of 2026, the platform has no verified references in central government, local authorities, housing, MOD or other regulated sectors. Aspyre's messaging is beginning to broaden toward regulated sectors, but the data model remains NHS-built. For organisations that need a platform proven across multiple public sector verticals, Verto's cross-sector track record is directly relevant.

How does Aspyre handle ICB-level portfolio management across Trusts and partner organisations?

Aspyre's architecture is designed around individual NHS organisations. For Integrated Care Boards that need to roll up programmes across multiple Trusts, councils, housing partners and other non-NHS bodies, Aspyre's NHS-only footprint becomes a structural constraint. Organisations outside the NHS data model cannot be meaningfully included in the portfolio governance picture. Verto's cross-organisation P3M is designed for exactly this ICB-to-Trust-to-partner roll-up scenario, including non-NHS bodies in the same portfolio view.

What is the vendor scale risk of procuring from Aspyre by Mosaique?

Mosaique Ltd is a micro-entity per Companies House, with approximately nine staff, family-only directors and an estimated annual revenue of between £500,000 and £1.5 million. There are no external investors, no non-executive directors and no external governance oversight. For a multi-year mission-critical portfolio management contract, procurement teams should assess vendor scale, balance sheet stability and business continuity carefully. Verto has an organisational scale, governance structure and balance sheet appropriate for long-term public sector contracts.

Does Aspyre integrate with Microsoft Teams, Power BI or ServiceNow?

Aspyre does not currently offer published integrations with Microsoft Teams, Power BI or ServiceNow. The platform sits largely outside the modern integration stack that many NHS organisations are building around M365 and enterprise data reporting tools. For PMOs that want portfolio data to surface in Power BI dashboards or Teams channels used by senior stakeholders, this is a meaningful gap. Verto has an integration story covering Power BI and Teams, allowing portfolio data to connect with the tools decision-makers already use.

What AI features does Aspyre currently offer?

Aspyre does not have a published AI roadmap and has not announced shipped AI features as of 2026. The platform's development cadence has been incremental, with version 10.3 released in 2025. For NHS organisations beginning to consider how AI can support portfolio reporting, prioritisation and resource forecasting, the absence of an AI roadmap from Aspyre is worth factoring into a long-term platform decision. Verto has AI functionality built into the platform.

How does Aspyre's methodology compare to Verto's for UK public sector governance?

Aspyre's methodology foundation is MSP, PRINCE2 and P3O. Founder Claire Cassidy is one of the UK's earliest MSP Advanced Practitioners, and this expertise is evident in the platform's design. This is a real strength for NHS organisations aligned to those frameworks. Verto covers the same methodology breadth and extends into IPA, MoP, Praxis and HMT Green Book alignment. For NHS organisations that also engage with DHSC assurance frameworks or IPA reviews, Verto's broader methodology coverage is directly relevant.

Aspyre has NHS England managing a £2.5bn portfolio. How does Verto compare on NHS credentials?

NHS England is Aspyre's marquee reference and it is a significant one that should be taken seriously in any evaluation. Verto's NHS reference base spans multiple NHS organisations, and unlike Aspyre, Verto's 100+ UK public sector clients extend across NHS, central government, local authorities, MOD and housing. For ICBs managing programmes that involve non-NHS partners, that cross-sector breadth is directly relevant to the governance picture. For a single NHS Trust with no cross-sector complexity, both platforms are credible and the evaluation should focus on integration, AI roadmap and vendor scale.

Next steps

Evaluating platforms for an NHS or health and care portfolio function?

If your shortlist includes Aspyre alongside Verto, we are happy to walk through a comparison focused on your specific context, whether that is ICB cross-partner complexity, integration requirements, or a like-for-like methodology discussion.

Talk to our team See Verto in action

Focus, collaborate, deliver with confidence